TerraVia receives FDA generally recognized as safe letter for Algae Butter


In California, TerraVia Holdings, Inc. received a generally recognized as safe no questions letter from the U.S. Food and Drug Administration for its Algae Butter, a palm-free, non-hydrogenated, vegan solution for bakery, spreads and confectionery applications. Quick melting with a clean taste, Algae Butter can reduce saturated fat by up to 50 percent in most applications.

“The food industry has been searching for a replacement for palm and hydrogenated vegetable oils that maintains quality, taste and functionality and also meets their rigorous criteria for sustainable sourcing,” said Mark Brooks, Senior Vice President, TerraVia. “We believe Algae butter is a game changer for the structuring fats industry in terms of sustainability and nutrition.”

TerraVia and its joint venture partner, Bunge North America, will commercialize this revolutionary structuring fat. Algae Butter will be produced by the TerraVia and Bunge joint venture, SB Oils, and marketed in the U.S. by Bunge North America.